NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.42B
This Quarter Return
+37.02%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$1.04B
AUM Growth
+$1.04B
Cap. Flow
-$96.2M
Cap. Flow %
-9.25%
Top 10 Hldgs %
98.88%
Holding
20
New
1
Increased
2
Reduced
2
Closed
6
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ISEE
1
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$386M 37.06% 4,910,487
VTI icon
2
Vanguard Total Stock Market ETF
VTI
$526B
$311M 29.87% 2,979,100
INGN icon
3
Inogen
INGN
$216M
$142M 13.68% 3,549,320
VGK icon
4
Vanguard FTSE Europe ETF
VGK
$26.8B
$105M 10.07% 2,101,000
CLCD
5
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$25.6M 2.46% 3,056,563
TBRA
6
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$24.8M 2.39% 2,471,405 -225,000 -8% -$2.26M
PEN icon
7
Penumbra
PEN
$10.6B
$12.7M 1.22% 236,144 +131,200 +125% +$7.06M
NBRV
8
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$8.42M 0.81% 874,985 +7,858 +0.9% +$75.6K
IVTY
9
DELISTED
Invuity, Inc
IVTY
$8.16M 0.78% +925,000 New +$8.16M
HTGM
10
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$5.58M 0.54% 1,280,185
ELDN icon
11
Eledon Pharmaceuticals
ELDN
$155M
$4.11M 0.39% 470,946 -767,306 -62% -$6.69M
GKOS icon
12
Glaukos
GKOS
$5.5B
$1.85M 0.18% 75,000
XENE icon
13
Xenon Pharmaceuticals
XENE
$2.98B
$1.03M 0.1% 127,563
AKBA icon
14
Akebia Therapeutics
AKBA
$833M
-1,516,387 Closed -$14.6M
NVRO
15
DELISTED
NEVRO CORP.
NVRO
-625,704 Closed -$29M
OTIC
16
DELISTED
Otonomy, Inc.
OTIC
-875,025 Closed -$15.6M
ADAP
17
Adaptimmune Therapeutics
ADAP
$15.6M
-1,411,567 Closed -$16.9M
FLXN
18
DELISTED
Flexion Therapeutics, Inc.
FLXN
-1,033,131 Closed -$15.4M